BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20075332)

  • 21. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
    Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
    J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.
    Ho TJ; Huang CC; Huang CY; Lin WT
    Eur J Appl Physiol; 2012 Aug; 112(8):2943-55. PubMed ID: 22160250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
    Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
    Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
    Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
    J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress.
    Awad S; Al-Haffar KM; Marashly Q; Quijada P; Kunhi M; Al-Yacoub N; Wade FS; Mohammed SF; Al-Dayel F; Sutherland G; Assiri A; Sussman M; Bers D; Al-Habeeb W; Poizat C
    J Pathol; 2015 Mar; 235(4):606-18. PubMed ID: 25421395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of cardiac hypertrophic signaling by prolyl isomerase Pin1.
    Toko H; Konstandin MH; Doroudgar S; Ormachea L; Joyo E; Joyo AY; Din S; Gude NA; Collins B; Völkers M; Thuerauf DJ; Glembotski CC; Chen CH; Lu KP; Müller OJ; Uchida T; Sussman MA
    Circ Res; 2013 Apr; 112(9):1244-52. PubMed ID: 23487407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
    Liu W; Zi M; Jin J; Prehar S; Oceandy D; Kimura TE; Lei M; Neyses L; Weston AH; Cartwright EJ; Wang X
    Circ Res; 2009 Apr; 104(7):905-14. PubMed ID: 19265040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
    Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
    J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
    Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
    J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deprivation of MKK7 in cardiomyocytes provokes heart failure in mice when exposed to pressure overload.
    Liu W; Zi M; Chi H; Jin J; Prehar S; Neyses L; Cartwright EJ; Flavell RA; Davis RJ; Wang X
    J Mol Cell Cardiol; 2011 Apr; 50(4):702-11. PubMed ID: 21284947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
    Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
    Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB
    Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
    Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
    Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redox Regulation of Cardiac ASK1 (Apoptosis Signal-Regulating Kinase 1) Controls p38-MAPK (Mitogen-Activated Protein Kinase) and Orchestrates Cardiac Remodeling to Hypertension.
    Meijles DN; Cull JJ; Markou T; Cooper STE; Haines ZHR; Fuller SJ; O'Gara P; Sheppard MN; Harding SE; Sugden PH; Clerk A
    Hypertension; 2020 Oct; 76(4):1208-1218. PubMed ID: 32903101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways.
    Kontaridis MI; Yang W; Bence KK; Cullen D; Wang B; Bodyak N; Ke Q; Hinek A; Kang PM; Liao R; Neel BG
    Circulation; 2008 Mar; 117(11):1423-35. PubMed ID: 18316486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload.
    Li WM; Zhao YF; Zhu GF; Peng WH; Zhu MY; Yu XJ; Chen W; Xu DC; Xu YW
    Clin Sci (Lond); 2017 Jan; 131(2):141-154. PubMed ID: 27702885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.